Statements (14)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:immunotherapy
|
gptkbp:administered_by |
oral tablet
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:can_be_combined_with |
gptkb:artemether
|
gptkbp:chemical_formula |
C30 H32 Cl3 N3 O
|
https://www.w3.org/2000/01/rdf-schema#label |
lumefantrine
|
gptkbp:mechanism_of_action |
inhibits the beta-hematin formation
|
gptkbp:side_effect |
dizziness
headache nausea |
gptkbp:used_for |
treatment of malaria
|
gptkbp:bfsParent |
gptkb:Pentacarinat
gptkb:artemisinin-based_therapies |
gptkbp:bfsLayer |
7
|